Omicron Clouds Novavax’s Delayed COVID-19 Vaccine Debut

After Repeated Delays, Investors Doubt Readiness

 
• By Andrew McConaghie
  
Novavax
Novavax looks on track to gain an EUA in the US and Europe in early 2022, but may need to develop a new Omicron-targeting version of the vaccine. • Source: Getty Images
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip